{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:43:31Z","timestamp":1790912611525,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bristol Myers Squibb"},{"name":"Janssen Global Services, LLC, a Johnson & Johnson Company"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Thrombotic cardiovascular diseases profoundly impact patients\u2019 health-related quality of life (HRQoL). However, patient-reported outcome (PRO) instruments that are disease-specific or antithrombotic-treatment focused, developed according to US Food and Drug Administration (FDA) guidance on PROs, and can be used in clinical trials, are lacking. The aim of this study was to understand concepts important to patients diagnosed with coronary artery disease (CAD) or acute coronary syndrome (ACS), atrial fibrillation (AF), or stroke who require antithrombotic treatment for reducing risk of future thrombotic events (indications being evaluated for an investigational new drug), identify PROs that measure relevant symptoms and impacts, and determine acceptability of PROs from a health technology assessment (HTA) perspective.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A landscape review, conducted between January 2009 and October 2020, included a search of qualitative literature (OVID), a review of PRO instruments using multiple sources (e.g., OVID and clinical trials databases), and a survey of HTA decisions for antithrombotic medications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The qualitative literature review identified 27 publications used to develop a high-level conceptual summary of symptoms and HRQoL impacts reported by patients. The instrument landscape review indicated that generic PROs have been utilized for thrombotic indications, but disease-specific, fit-for-purpose instruments are lacking, and the HTA review revealed that although HTA agencies discussed PRO instruments, evidence of specific recommendations was not found.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>To ensure patients\u2019 experiences, perspectives, and priorities are incorporated into drug development and evaluation, a core set of PROs for thrombotic indications that meet health authority guidance and are acceptable to HTA agencies is needed.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11136-024-03790-1","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T13:45:10Z","timestamp":1732283110000},"page":"101-111","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A landscape review to identify what matters to patients with thrombotic cardiovascular diseases and patient-reported outcome instruments which can be used to capture the patient experience"],"prefix":"10.1007","volume":"34","author":[{"given":"Alexandra I.","family":"Barsdorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Fastenau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blue","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"3790_CR1","unstructured":"World Health Organization. (2021). Cardiovascular diseases (CVDs). Retrieved from www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds). Accessed on October 29, 2021."},{"issue":"9","key":"3790_CR2","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe, A. M., & Raskob, G. E. (2016). Global burden of thrombosis: Epidemiologic aspects. Circulation Research, 118(9), 1340\u20131347. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306841","journal-title":"Circulation Research"},{"issue":"16","key":"3790_CR3","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1056\/NEJMcp043511","volume":"352","author":"BH Dobkin","year":"2005","unstructured":"Dobkin, B. H. (2005). Clinical practice. Rehabilitation after stroke. New England Journal of Medicine, 352(16), 1677\u20131684. https:\/\/doi.org\/10.1056\/NEJMcp043511","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"3790_CR4","doi-asserted-by":"publisher","first-page":"931","DOI":"10.5664\/jcsm.9082","volume":"17","author":"LA Frojd","year":"2021","unstructured":"Frojd, L. A., Munkhaugen, J., Moum, T., Sverre, E., Nordhus, I. H., Papageorgiou, C., & Dammen, T. (2021). Insomnia in patients with coronary heart disease: Prevalence and correlates. Journal of Clinical Sleep Medicine, 17(5), 931\u2013938. https:\/\/doi.org\/10.5664\/jcsm.9082","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"3","key":"3790_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5664\/jcsm.7684","volume":"15","author":"MT Madsen","year":"2019","unstructured":"Madsen, M. T., Huang, C., Zangger, G., Zwisler, A. D. O., & Gogenur, I. (2019). Sleep disturbances in patients with coronary heart disease: A systematic review. Journal of Clinical Sleep Medicine, 15(3), 489\u2013504. https:\/\/doi.org\/10.5664\/jcsm.7684","journal-title":"Journal of Clinical Sleep Medicine"},{"issue":"1","key":"3790_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s12955-017-0809-3","volume":"15","author":"L Mollon","year":"2017","unstructured":"Mollon, L., & Bhattacharjee, S. (2017). Health related quality of life among myocardial infarction survivors in the United States: A propensity score matched analysis. Health and Quality of Life Outcomes, 15(1), 235. https:\/\/doi.org\/10.1186\/s12955-017-0809-3","journal-title":"Health and Quality of Life Outcomes"},{"issue":"3","key":"3790_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ijnurstu.2013.06.012","volume":"51","author":"A Fors","year":"2014","unstructured":"Fors, A., Dudas, K., & Ekman, I. (2014). Life is lived forwards and understood backwards\u2013experiences of being affected by acute coronary syndrome: A narrative analysis. International Journal of Nursing Studies, 51(3), 430\u2013437.","journal-title":"International Journal of Nursing Studies"},{"issue":"21\u201322","key":"3790_CR8","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1111\/jocn.13715","volume":"26","author":"H Iles-Smith","year":"2017","unstructured":"Iles-Smith, H., Deaton, C., Campbell, M., Mercer, C., & McGowan, L. (2017). The experiences of myocardial infarction patients readmitted within six months of primary percutaneous coronary intervention. Journal of Clinical Nursing, 26(21\u201322), 3511\u20133518.","journal-title":"Journal of Clinical Nursing"},{"issue":"1","key":"3790_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12875-016-0573-1","volume":"18","author":"GM Dalmau","year":"2017","unstructured":"Dalmau, G. M., Arderiu, E. S., Montes, M. B. E., Sol\u00e0, I., Saco, S. P., & Coello, P. A. (2017). Patients\u2019 and physicians\u2019 perceptions and attitudes about oral anticoagulation and atrial fibrillation: A qualitative systematic review. BMC Family Practice, 18(1), 1\u201311.","journal-title":"BMC Family Practice"},{"issue":"6","key":"3790_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/MAJ.0000000000000349","volume":"348","author":"S Sen","year":"2014","unstructured":"Sen, S., & Dahlberg, K. W. (2014). Physician\u2019s fear of anticoagulant therapy in nonvalvular atrial fibrillation. American Journal of Medical Sciences, 348(6), 513\u2013521. https:\/\/doi.org\/10.1097\/MAJ.0000000000000349","journal-title":"American Journal of Medical Sciences"},{"key":"3790_CR11","unstructured":"Food and Drug Administration. Guidance for industry: Patient-reported outcome measures: use in medical product development to support labeling claims. Fed Regist. 2009;74:65132-65133."},{"key":"3790_CR12","unstructured":"COMET. Core Outcome Measures in Effectiveness Trials. Retrieved from https:\/\/www.comet-initiative.org\/. Accessed on October 29, 2021."},{"key":"3790_CR13","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1745-6215-15-247","volume":"15","author":"CA Prinsen","year":"2014","unstructured":"Prinsen, C. A., Vohra, S., Rose, M. R., King-Jones, S., Ishaque, S., Bhaloo, Z., Adams, D., & Terwee, C. B. (2014). Core Outcome Measures in Effectiveness Trials (COMET) initiative: Protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a \u2018core outcome set.\u2019 Trials, 15, 247. https:\/\/doi.org\/10.1186\/1745-6215-15-247","journal-title":"Trials"},{"key":"3790_CR14","unstructured":"US Food and Drug Administration. (2021). Core patient-reported outcomes in cancer clinical trials. Retrieved from https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/core-patient-reported-outcomes-cancer-clinical-trials. Accessed on November 15, 2021."},{"issue":"4","key":"3790_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ecco-jcc\/jjx161","volume":"12","author":"AH Kim","year":"2018","unstructured":"Kim, A. H., Roberts, C., Feagan, B. G., Banerjee, R., Bemelman, W., Bodger, K., Derieppe, M., Dignass, A., Driscoll, R., Fitzpatrick, R., Gaarentstroom-Lunt, J., Higgins, P. D., Kotze, P. G., Meissner, J., O\u2019Connor, M., Ran, Z. H., Suegek, C. A., Terry, H., et al. (2018). Developing a standard set of patient-centred outcomes for inflammatory bowel disease-an international, cross-disciplinary consensus. Journal of Crohns and Colitis, 12(4), 408\u2013418. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx161","journal-title":"Journal of Crohns and Colitis"},{"key":"3790_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks, R. (1996). EuroQol: The current state of play. Health Policy, 37, 53\u201372. https:\/\/doi.org\/10.1016\/0168-8510(96)00822-6","journal-title":"Health Policy"},{"key":"3790_CR17","volume-title":"SF-36 health survey: Manual and interpretation guide","author":"JE Ware","year":"1993","unstructured":"Ware, J. E. (1993). Scoring the SF-36. SF-36 health survey: Manual and interpretation guide. Boston: The Health Institute."},{"issue":"1","key":"3790_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-10-120","volume":"10","author":"SJ Cano","year":"2012","unstructured":"Cano, S. J., Lamping, D. L., Bamber, L., & Smith, S. (2012). The Anti-Clot Treatment Scale (ACTS) in clinical trials: Cross-cultural validation in venous thromboembolism patients. Health and Quality of Life Outcomes, 10(1), 1\u201311.","journal-title":"Health and Quality of Life Outcomes"},{"key":"3790_CR19","first-page":"A10977","volume":"126","author":"LP Kimble","year":"2012","unstructured":"Kimble, L. P., & Momary, K. M. (2012). A novel self-report measure of nuisance bleeding following chronic antiplatelet drug therapy. Circulation, 126, A10977.","journal-title":"Circulation"},{"issue":"Suppl 1","key":"3790_CR20","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1524-4733.2005.00066.x","volume":"8","author":"MJ Atkinson","year":"2005","unstructured":"Atkinson, M. J., Kumar, R., & Cappelleri, J. C. (2005). Hierarchical construct validity of the Treatment Satisfaction Questionnaire for Medication (TSQM version II) among outpatient pharmacy consumers. Value in Health, 8(Suppl 1), S9\u2013S24.","journal-title":"Value in Health"},{"issue":"5","key":"3790_CR21","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","volume":"7","author":"PS Chan","year":"2014","unstructured":"Chan, P. S., Jones, P. G., Arnold, S. A., & Spertus, J. A. (2014). Development and validation of a short version of the Seattle Angina Questionnaire. Circulation, 7(5), 640\u2013647. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.114.000967","journal-title":"Circulation"},{"issue":"11","key":"3790_CR22","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","volume":"41","author":"K Kroenke","year":"2003","unstructured":"Kroenke, K., Spitzer, R. L., & Williams, J. B. (2003). The Patient Health Questionnaire-2: Validity of a two-item depression screener. Medical Care, 41(11), 1284\u20131292.","journal-title":"Medical Care"},{"key":"3790_CR23","first-page":"1","volume-title":"Monograph series","author":"GA Rose","year":"1968","unstructured":"Rose, G. A., & Blackburn, H. (1968). Cardiovascular survey methods. Monograph series (Vol. 56, pp. 1\u2013188). World Health Organization."},{"key":"3790_CR24","unstructured":"International Consortium for Health Outcomes Measurement (ICHOM). (2017). Coronary artery disease data collection reference guide. Retrieved November 10, 2020, from https:\/\/ichom.org\/files\/medical-conditions\/coronary-artery-disease\/coronary-artery-disease-reference-guide.pdf"},{"issue":"5","key":"3790_CR25","doi-asserted-by":"publisher","first-page":"e001767","DOI":"10.1161\/JAHA.115.001767","volume":"4","author":"RL McNamara","year":"2015","unstructured":"McNamara, R. L., Spatz, E. S., Kelley, T. A., Stowell, C. J., Beltrame, J., Heidenreich, P., Tresserras, R., Jernberg, T., Chua, T., Morgan, L., Panigrahi, B., Ruiz, A. R., Rumsfeld, J. S., Sadwin, L., Schoeberl, M., Shahian, D., Weston, C., Yeh, R., & Lewin, J. (2015). Standardized outcome measurement for patients with coronary artery disease: Consensus from the International Consortium for Health Outcomes Measurement (ICHOM). Journal of the American Heart Association, 4(5), e001767.","journal-title":"Journal of the American Heart Association"},{"issue":"3","key":"3790_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"J Ware Jr","year":"1996","unstructured":"Ware, J., Jr., Kosinski, M., & Keller, S. D. (1996). A 12-item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220\u2013233.","journal-title":"Medical Care"},{"issue":"7","key":"3790_CR27","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","volume":"18","author":"RD Hays","year":"2009","unstructured":"Hays, R. D., Bjorner, J. B., Revicki, D. A., Spritzer, K. L., & Cella, D. (2009). Development of physical and mental health summary scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items. Quality of Life Research, 18(7), 873\u2013880. https:\/\/doi.org\/10.1007\/s11136-009-9496-9","journal-title":"Quality of Life Research"},{"key":"3790_CR28","unstructured":"International Consortium for Health Outcomes Measurement (ICHOM). (2019a). Atrial fibrillation data collection reference guide. Retrieved November 10, 2020, from https:\/\/ichom.org\/files\/medical-conditions\/atrial-fibrillation\/atrial-fibrillation-reference-guide.pdf"},{"issue":"10","key":"3790_CR29","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/eurheartj\/ehz871","volume":"41","author":"WH Seligman","year":"2020","unstructured":"Seligman, W. H., Das-Gupta, Z., Jobi-Odeneye, A. O., Arbelo, E., Banerjee, A., Bollmann, A., Caffrey-Armstrong, B., Cehic, D. A., Corbalan, R., Collins, M., Dandamudi, G., Dorairaj, P., Fay, M., Van Gelder, I. C., Goto, S., Granger, C. B., Gyorgy, B., Healey, J. S., & Hendriks, J. M. (2020). Development of an international standard set of outcome measures for patients with atrial fibrillation: A report of the International Consortium for Health Outcomes Measurement (ICHOM) Atrial Fibrillation Working Group. European Heart Journal, 41(10), 1132\u20131140.","journal-title":"European Heart Journal"},{"issue":"1","key":"3790_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/CIRCEP.110.958033","volume":"4","author":"J Spertus","year":"2011","unstructured":"Spertus, J., Dorian, P., Bubien, R., Lewis, S., Godejohn, D., Reynolds, M. R., Lakkireddy, D. R., Wimmer, A. P., Bhandari, A., & Burk, C. (2011). Development and validation of the Atrial Fibrillation Effect on Quality of Life (AFEQT) questionnaire in patients with atrial fibrillation. Circulation Arrhythmia Electrophysiology, 4(1), 15\u201325.","journal-title":"Circulation Arrhythmia Electrophysiology"},{"issue":"4","key":"3790_CR31","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/s0735-1097(00)00886-x","volume":"36","author":"P Dorian","year":"2000","unstructured":"Dorian, P., Jung, W., Newman, D., Paquette, M., Wood, K., Ayers, G. M., Camm, J., Akhtar, M., & Luderitz, B. (2000). The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. Journal of the American College of Cardiology, 36(4), 1303\u20131309. https:\/\/doi.org\/10.1016\/s0735-1097(00)00886-x","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"3790_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993). The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics, 4(5), 353\u2013365.","journal-title":"PharmacoEconomics"},{"issue":"1","key":"3790_CR33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jclinepi.2006.06.025","volume":"61","author":"M Rose","year":"2008","unstructured":"Rose, M., Bjorner, J. B., Becker, J., Fries, J. F., & Ware, J. E. (2008). Evaluation of a preliminary physical function item bank supported the expected advantages of the Patient-Reported Outcomes Measurement Information System (PROMIS). Journal of Clinical Epidemiology, 61(1), 17\u201333.","journal-title":"Journal of Clinical Epidemiology"},{"key":"3790_CR34","unstructured":"International Consortium for Health Outcomes Measurement (ICHOM). (2019b). Stroke data collection reference guide. Retrieved November 10, 2020, from https:\/\/ichom.org\/files\/medical-conditions\/stroke\/stroke-reference-guide.pdf"},{"key":"3790_CR35","unstructured":"American College of Cardiology (ACC). Patient reported outcomes forum. Retrieved November 15, from https:\/\/www.acc.org\/tools-and-practice-support\/quality-programs\/features\/forums-and-summits\/patient-reported-outcomes-forum. Accessed on November 15, 2021."},{"issue":"2","key":"3790_CR36","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","volume":"25","author":"JA Spertus","year":"1995","unstructured":"Spertus, J. A., Winder, J. A., Dewhurst, T. A., Deyo, R. A., Prodzinski, J., McDonell, M., & Fihn, S. D. (1995). Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease. Journal of the American College of Cardiology, 25(2), 333\u2013341.","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"3790_CR37","first-page":"635","volume":"7","author":"SM Bradley","year":"2014","unstructured":"Bradley, S. M. (2014). The routine clinical capture of patient-reported outcomes: How competition on value will lead to change. Circulation, 7(5), 635\u2013636.","journal-title":"Circulation"},{"issue":"5","key":"3790_CR38","first-page":"640","volume":"7","author":"PS Chan","year":"2014","unstructured":"Chan, P. S., Jones, P. G., Arnold, S. A., & Spertus, J. A. (2014). Development and validation of a short version of the Seattle Angina Questionnaire. Circulation, 7(5), 640\u2013647.","journal-title":"Circulation"},{"issue":"11","key":"3790_CR39","doi-asserted-by":"publisher","first-page":"e0165790","DOI":"10.1371\/journal.pone.0165790","volume":"11","author":"D Kotecha","year":"2016","unstructured":"Kotecha, D., Ahmed, A., Calvert, M., Lencioni, M., Terwee, C. B., & Lane, D. A. (2016). Patient-reported outcomes for quality of life assessment in atrial fibrillation: A systematic review of measurement properties. PLoS ONE, 11(11), e0165790.","journal-title":"PLoS ONE"},{"issue":"4","key":"3790_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00006842-199807000-00014","volume":"60","author":"MD Sullivan","year":"1998","unstructured":"Sullivan, M. D., LaCroix, A. Z., Russo, J., & Katon, W. J. (1998). Self-efficacy and self-reported functional status in coronary heart disease: a six-month prospective study. Psychosomatic Medicine, 60(4), 473\u2013478. https:\/\/doi.org\/10.1097\/00006842-199807000-00014","journal-title":"Psychosomatic Medicine"},{"issue":"1","key":"3790_CR41","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/2047487312450544","volume":"21","author":"N Oldridge","year":"2014","unstructured":"Oldridge, N., H\u00f6fer, S., McGee, H., Conroy, R., Doyle, F., Saner, H., HeartQoL Project Investigators. (2014). The HeartQoL: Part I. Development of a new core health-related quality of life questionnaire for patients with ischemic heart disease. European Journal of Preventive Cardiology, 21(1), 90\u201397. https:\/\/doi.org\/10.1177\/2047487312450544","journal-title":"European Journal of Preventive Cardiology"},{"issue":"11","key":"3790_CR42","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/0895-4356(94)90134-1","volume":"47","author":"TK Hillers","year":"1994","unstructured":"Hillers, T. K., Guyatt, G. H., Oldridge, N., Crowe, J., Willan, A., Griffith, L., & Feeny, D. (1994). Quality of life after myocardial infarction. Journal of Clinical Epidemiology, 47(11), 1287\u20131296.","journal-title":"Journal of Clinical Epidemiology"},{"key":"3790_CR43","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00435980","volume":"5","author":"L Valenti","year":"1996","unstructured":"Valenti, L., Lim, L., Heller, R. F., & Knapp, J. (1996). An improved questionnaire for assessing quality of life after myocardial infarction. Quality of Life Research, 5, 151\u2013161.","journal-title":"Quality of Life Research"},{"key":"3790_CR44","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1161\/01.STR.30.10.2131","volume":"30","author":"PW Duncan","year":"1993","unstructured":"Duncan, P. W., Wallace, D., Lai, S. M., Johnson, D., Embretson, S., & Laster, L. J. (1993). The Stroke Impact Scale version 2.0. Evaluation of reliability, validity and sensitivity to change. Stroke, 30, 2131\u20132140.","journal-title":"Stroke"},{"issue":"7","key":"3790_CR45","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S0003-9993(03)00035-2","volume":"84","author":"PW Duncan","year":"2003","unstructured":"Duncan, P. W., Bode, R. K., Min Lai, S., & Perera, S. (2003). Glycine antagonist in neuroprotection Americans investigators. Rasch analysis of a new stroke-specific outcome scale: the Stroke Impact Scale. Archives of Physical Medicine and Rehabilitation, 84(7), 950\u2013963.","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"2","key":"3790_CR46","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1212\/01.WNL.0000041493.65665.D6","volume":"60","author":"PW Duncan","year":"2003","unstructured":"Duncan, P. W., Lai, S. M., Bode, R. K., Perera, S., & DeRosa, J. (2003). Stroke Impact Scale-16: A brief assessment of physical function. Neurology, 60(2), 291\u2013296.","journal-title":"Neurology"},{"issue":"2\u20133","key":"3790_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000075783","volume":"17","author":"D Buck","year":"2004","unstructured":"Buck, D., Jacoby, A., Massey, A., Steen, N., Sharma, A., & Ford, G. A. (2004). Development and validation of NEWSQOL, the Newcastle Stroke-Specific Quality of Life measure. Cerebrovascular Diseases, 17(2\u20133), 143\u2013152.","journal-title":"Cerebrovascular Diseases"},{"key":"3790_CR48","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1161\/01.STR.30.7.1362","volume":"30","author":"LS Williams","year":"1999","unstructured":"Williams, L. S., Weinberger, M., Harris, L. E., Clark, D. O., & Biller, J. (1999). Development of a stroke-specific quality of life scale. Stroke, 30, 1362\u20131369.","journal-title":"Stroke"},{"issue":"10","key":"3790_CR49","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jval.2017.06.005","volume":"20","author":"KS Coyne","year":"2017","unstructured":"Coyne, K. S., Edvardsson, N., & Ryd\u00e9n, A. (2017). Development and validation of the AFImpact: an atrial fibrillation-specific measure of patient-reported health-related quality of life. Value in Health, 20(10), 1355\u20131361.","journal-title":"Value in Health"},{"key":"3790_CR50","first-page":"839","volume":"21","author":"C Maglio","year":"1998","unstructured":"Maglio, C., Sra, J., Paquette, M., Dorian, P., Bygrave, A., Wook, K., & Ayers, G. M. (1998). Measuring quality of life and symptom severity in patients with atrial fibrillation (abstract). Pacing and Clinical Electrophysiology, 21, 839.","journal-title":"Pacing and Clinical Electrophysiology"},{"issue":"5","key":"3790_CR51","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1477-7525-5-37","volume":"4","author":"X Badia","year":"2007","unstructured":"Badia, X., Arribas, F., Ormaetxe, J. M., Peinado, R., & de Los Terreros, M. S. (2007). Development of a questionnaire to measure health-related quality of life (HRQoL) in patients with atrial fibrillation (AF-QoL). Health and Quality of Life Outcomes, 4(5), 37.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"7","key":"3790_CR52","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-7525-7-9","volume":"6","author":"MH Prins","year":"2009","unstructured":"Prins, M. H., Marrel, A., Carita, P., Anderson, D., Bousser, M. G., Crijns, H., Consoli, S., & Arnould, B. (2009). Multinational development of a questionnaire assessing patient satisfaction with anti-coagulant treatment: The Perception of Anticoagulant Treatment Questionnaire (PACT-Q). Health and Quality of Life Outcomes, 6(7), 9.","journal-title":"Health and Quality of Life Outcomes"},{"issue":"6","key":"3790_CR53","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5694\/j.1326-5377.2003.tb05193.x","volume":"178","author":"SJ Bunker","year":"2003","unstructured":"Bunker, S. J., Colquhoun, D. M., Esler, M. D., Hickie, I. B., Hunt, D., Jelinek, V. M., Oldenburg, B. F., Peach, H. G., Ruth, D., Tennant, C. C., & Tonkin, A. M. (2003). \u201cStress\u201d and coronary heart disease: Psychosocial risk factors. The Medical Journal of Australia, 178(6), 272\u2013276. https:\/\/doi.org\/10.5694\/j.1326-5377.2003.tb05193.x","journal-title":"The Medical Journal of Australia"},{"issue":"23","key":"3790_CR54","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1001\/jama.2020.23068","volume":"324","author":"EL Harshfield","year":"2020","unstructured":"Harshfield, E. L., Pennells, L., Schwartz, J. E., Willeit, P., Kaptoge, S., Bell, S., Shaffer, J. A., Bolton, T., Spackman, S., Wassertheil-Smoller, S., Kee, F., Amouyel, P., Shea, S. J., Kuller, H., Kauhanen, J., van Zutphen, E. M., Blazer, D. G., Krumholz, H., Nietert, P. J., \u2026 Emerging Risk Factors Collaboration. (2020). Association between depressive symptoms and incident cardiovascular diseases. JAMA, 324(23), 2396\u20132405. https:\/\/doi.org\/10.1001\/jama.2020.23068","journal-title":"JAMA"},{"issue":"10","key":"3790_CR55","doi-asserted-by":"publisher","first-page":"e763","DOI":"10.1161\/CIR.0000000000000947","volume":"143","author":"GN Levine","year":"2021","unstructured":"Levine, G. N., Cohen, B. E., Commodore-Mensah, Y., Fleury, J., Huffman, J. C., Khalid, U., Labarthe, D. R., Lavretsky, H., Michos, D. D., Spatz, E. S., & Kubzansky, L. D. (2021). Psychological health, well-being, and the mind-heart-body connection: A scientific statement from the American Heart Association. Circulation, 143(10), e763\u2013e783. https:\/\/doi.org\/10.1161\/CIR.0000000000000947","journal-title":"Circulation"},{"issue":"11","key":"3790_CR56","doi-asserted-by":"publisher","first-page":"e6064","DOI":"10.7759\/cureus.6064","volume":"11","author":"K Mal","year":"2019","unstructured":"Mal, K., Awan, I. D., Ram, J., & Shaukat, F. (2019). Depression and anxiety as a risk factor for myocardial infarction. Cureus, 11(11), e6064. https:\/\/doi.org\/10.7759\/cureus.6064","journal-title":"Cureus"},{"issue":"3","key":"3790_CR57","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/jth.12480","volume":"12","author":"MJ Engbers","year":"2014","unstructured":"Engbers, M. J., Blom, J. W., Cushman, M., Rosendaal, F. R., & van Hylckama Vlieg, A. (2014). The contribution of immobility risk factors to the incidence of venous thrombosis in an older population. Journal of Thrombosis and Haemostasis, 12(3), 290\u2013296. https:\/\/doi.org\/10.1111\/jth.12480","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"1","key":"3790_CR58","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1089\/heq.2019.0065","volume":"3","author":"ML Wilby","year":"2019","unstructured":"Wilby, M. L. (2019). Physical mobility impairment and risk for cardiovascular disease. Health Equity, 3(1), 527\u2013531. https:\/\/doi.org\/10.1089\/heq.2019.0065","journal-title":"Health Equity"},{"issue":"46","key":"3790_CR59","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1093\/eurheartj\/ehu364","volume":"35","author":"K Kolandaivelu","year":"2014","unstructured":"Kolandaivelu, K., Leiden, B. B., O\u2019Gara, P. T., & Bhatt, D. L. (2014). Non-adherence to cardiovascular medications. European Heart Journal, 35(46), 3267\u20133276. https:\/\/doi.org\/10.1093\/eurheartj\/ehu364","journal-title":"European Heart Journal"},{"issue":"9","key":"3790_CR60","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"SH Naderi","year":"2012","unstructured":"Naderi, S. H., Bestwick, J. P., & Wald, D. S. (2012). Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. The American Journal of Medicine, 125(9), 882\u2013887. https:\/\/doi.org\/10.1016\/j.amjmed.2011.12.013","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"3790_CR61","doi-asserted-by":"publisher","first-page":"e005969","DOI":"10.1161\/CIRCOUTCOMES.119.005969","volume":"13","author":"AF Ozaki","year":"2020","unstructured":"Ozaki, A. F., Choi, A. S., Le, Q. T., Ko, D. T., Han, J. K., Park, S. S., & Jackevicius, C. A. (2020). Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: A systematic review and meta-analysis. Circulation, 13(3), e005969. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.119.005969","journal-title":"Circulation"},{"issue":"5","key":"3790_CR62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.18553\/jmcp.2018.24.5.440","volume":"24","author":"CL Rodriguez-Bernal","year":"2018","unstructured":"Rodriguez-Bernal, C. L., Peiro, S., Hurtado, I., Garcia-Sempere, A., & Sanfelix-Gimeno, G. (2018). Primary nonadherence to oral anticoagulants in patients with atrial fibrillation: Real-world data from a population-based cohort. Journal of Managed Care and Specialty Pharmacy, 24(5), 440\u2013448. https:\/\/doi.org\/10.18553\/jmcp.2018.24.5.440","journal-title":"Journal of Managed Care and Specialty Pharmacy"},{"issue":"1\u20132","key":"3790_CR63","doi-asserted-by":"publisher","first-page":"12","DOI":"10.26719\/2003.9.1-2.12","volume":"9","author":"AM El-Gatit","year":"2003","unstructured":"El-Gatit, A. M., & Haw, M. (2003). Relationship between depression and non-adherence to anticoagulant therapy after valve replacement. Eastern Mediterranean Health Journal, 9(1\u20132), 12\u201319.","journal-title":"Eastern Mediterranean Health Journal"},{"issue":"3\u20134","key":"3790_CR64","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000371574","volume":"73","author":"C Gumbinger","year":"2015","unstructured":"Gumbinger, C., Holstein, T., Stock, C., Rizos, T., Horstmann, S., & Veltkamp, R. (2015). Reasons underlying non-adherence to and discontinuation of anticoagulation in secondary stroke prevention among patients with atrial fibrillation. European Neurology, 73(3\u20134), 184\u2013191. https:\/\/doi.org\/10.1159\/000371574","journal-title":"European Neurology"},{"issue":"1","key":"3790_CR65","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12872-019-1019-1","volume":"19","author":"SR Reading","year":"2019","unstructured":"Reading, S. R., Black, M. H., Singer, D. E., Go, A. S., Fang, M. C., Udaltsova, N., Harrison, T. N., Wei, R. X., Liu, I. L. A., Reynolds, K., ATRIA-CRVN Investigators. (2019). Risk factors for medication non-adherence among atrial fibrillation patients. BMC Cardiovascular Disorders, 19(1), 38. https:\/\/doi.org\/10.1186\/s12872-019-1019-1","journal-title":"BMC Cardiovascular Disorders"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03790-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-024-03790-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-024-03790-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T14:14:13Z","timestamp":1738851253000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-024-03790-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["3790"],"URL":"https:\/\/doi.org\/10.1007\/s11136-024-03790-1","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"assertion":[{"value":"12 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AIB is an employee of Clinical Outcomes Solutions, a company that received funding from the sponsors. BS was an employee of Clinical Outcomes Solutions at the time of this study. SL is an employee of FingerPost Consulting, a company that received funding from the sponsors. JF was an employee of Janssen Global Services, LLC, a Johnson & Johnson Company at the time of this study. EO is an employee of Janssen Global Services, LLC, a Johnson & Johnson Company. XL and BB are employees of Bristol Myers Squibb.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This study did not involve human or animal subjects.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study did not involve human subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"This study did not involve human subjects.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}